Combination antiretroviral therapy (cART)-induced hippocampal disorders: Highlights on therapeutic potential of Naringenin and Quercetin. (June 2019)
- Record Type:
- Journal Article
- Title:
- Combination antiretroviral therapy (cART)-induced hippocampal disorders: Highlights on therapeutic potential of Naringenin and Quercetin. (June 2019)
- Main Title:
- Combination antiretroviral therapy (cART)-induced hippocampal disorders: Highlights on therapeutic potential of Naringenin and Quercetin
- Authors:
- Akang, Edidiong N.
Dosumu, Olufunke O.
Afolayan, Olasunmbo O.
Fagoroye, Adeola M.
Osiagwu, Daniel D.
Usman, Isilamiyat T.
Oremosu, Ademola A.
Akanmu, Alani S. - Abstract:
- Highlights: Naringenin and Quercetin decrease ROS and potentiate enzymatic antioxidant production in the hippocampus. cART induced marked cytoplasmic shrinkage and several pyknotic nuclei in the dentate gyrus and cornus ammonis region. Naringenin and Quercetin attenuates cART-induced upregulation of monoamine oxidase-B expression in neurons. Naringenin and Quercetin also ameliorates cART-induced spatial memory impairments. Naringenin and Quercetin acted as effective antioxidants in vivo against cART-induced neurotoxicity. Abstract: Introduction: In spite of the multiple benefits of combination antiretroviral therapy (cART) on HIV positive patients, prolonged usage has been reported to exacerbate oxidative stress, and induce neurological and cognitive dysfunction, thus, the need to search for an adjuvant therapy to ameliorate the oxidative and improve treatment adherence with better virological outcome. This study aimed at determining the potential therapeutic effects of Quercetin and Naringenin on cART-induced cyto-architectural, neuro-behavioral and immunohistochemical changes in the hippocampus of the adult Wister rats. Materials and Methods: The animals were grouped as follows: Control, DMSO, 24 mg/kg cART (Tenovovir 300 mg, Lamivudine 300 mg and Efavirenz 600 mg), 50 mg/kg Naringenin, 50 mg/kg Quercetin, cART + Naringenin, cART + Quercetin were administered orally for 8 weeks. At the end of administration, neurobehavioural test was conducted, animals were euthanized andHighlights: Naringenin and Quercetin decrease ROS and potentiate enzymatic antioxidant production in the hippocampus. cART induced marked cytoplasmic shrinkage and several pyknotic nuclei in the dentate gyrus and cornus ammonis region. Naringenin and Quercetin attenuates cART-induced upregulation of monoamine oxidase-B expression in neurons. Naringenin and Quercetin also ameliorates cART-induced spatial memory impairments. Naringenin and Quercetin acted as effective antioxidants in vivo against cART-induced neurotoxicity. Abstract: Introduction: In spite of the multiple benefits of combination antiretroviral therapy (cART) on HIV positive patients, prolonged usage has been reported to exacerbate oxidative stress, and induce neurological and cognitive dysfunction, thus, the need to search for an adjuvant therapy to ameliorate the oxidative and improve treatment adherence with better virological outcome. This study aimed at determining the potential therapeutic effects of Quercetin and Naringenin on cART-induced cyto-architectural, neuro-behavioral and immunohistochemical changes in the hippocampus of the adult Wister rats. Materials and Methods: The animals were grouped as follows: Control, DMSO, 24 mg/kg cART (Tenovovir 300 mg, Lamivudine 300 mg and Efavirenz 600 mg), 50 mg/kg Naringenin, 50 mg/kg Quercetin, cART + Naringenin, cART + Quercetin were administered orally for 8 weeks. At the end of administration, neurobehavioural test was conducted, animals were euthanized and hippocampus was processed for oxidative stress markers, histology, TNF-α, and Monoamine oxidase-B expression. Results: At the end of 8 weeks of administration, 24 mg/kg cART decreased superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH) and increased Malondialdehyde (MDA). Whereas, 50 mg/kg quercetin, and 50 mg/kg Naringenin decreased the oxidative stress (increased SOD, CAT, GSH, and reduced MDA) induced by cART (reduced SOD, CAT, GSH, and increased MDA). In addition, hematoxylin and eosin stained hippocampus showed that quercetin and naringenin prevented neurodegenerative changes (marked cytoplasmic shrinkage and several pyknotic nuclei in the dentate gyrus and cornus ammonis regions) in cART-treated rats. Furthermore, immunohistochemical studies revealed that quercetin and naringenin attenuates cART-induced upregulation of monoamine oxidase-B (MAO-B) expression. Likewise, from the Morris water maze neurobehavioral studies, naringenin and quercetin also ameliorated cART-induced memory impairments (initial spatial memory, reversal spatial memory and probe tests). Conclusion: This study shows that Naringenin and Quercetin have a good potential in reversing cART-induced hippocampal disorders in Wistar rats. … (more)
- Is Part Of:
- IBRO reports. Volume 6(2019)
- Journal:
- IBRO reports
- Issue:
- Volume 6(2019)
- Issue Display:
- Volume 6, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 6
- Issue:
- 2019
- Issue Sort Value:
- 2019-0006-2019-0000
- Page Start:
- 137
- Page End:
- 146
- Publication Date:
- 2019-06
- Subjects:
- cART combination antiretroviral therapy -- MAO-B monoamine oxidase B -- TNFα tumor necrosis factor alpha -- CAT catalase -- GSH reduced glutathione -- SOD superoxide dismutase -- MDA malondialdehyde -- TBA thiobarbituric acid -- ELISA enzyme-linked immunosorbent assay -- HCL hydrochloric acidE -- DTA ethylenediaminetetraacetic acid -- ROS reactive oxygen species -- DMSO dimethyl sulfoxide -- Nar naringenin -- Quer quercetin -- cA/N 24 mg/kg combination antiretroviral therapy + 50 mg Naringenin -- CA/Q 24 mg/kg combination antiretroviral therapy + 50 mg Quercetin
Neurodegeneration -- cART -- Naringenin -- Quercetin -- Hippocampus -- Oxidative stress
Nervous system -- Periodicals
Brain -- Periodicals
Brain -- Research -- Periodicals
Nervous system
Brain -- Research
Brain
Neurology
Nervous System Physiological Phenomena
Electronic journals
Periodicals
Fulltext
Internet Resources
Periodicals
Periodical - Journal URLs:
- https://www.ncbi.nlm.nih.gov/pmc/journals/3512/ ↗
http://www.journals.elsevier.com/ibro-reports ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.ibror.2019.04.002 ↗
- Languages:
- English
- ISSNs:
- 2451-8301
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10728.xml